Metabolic dysfunction-associated fatty liver disease (MAFLD) poses a significant challenge in modern medicine due to its high prevalence. The pathogenesis of MAFLD involves a complex dysmetabolic ...

Cybin Inc. ( CYBN) Q2 2026 Earnings Call November 13, 2025 8:00 AM EST ...

May Lau, a Dallas-based doctor, has voluntarily surrendered her Texas medical license a year after being sued by Attorney General Ken Paxton for allegedly violating the state’s ban on gender-affirming ...

Revenue -- $1.2 million, representing a 32% increase, attributed primarily to higher procedure volumes for the Catamaran ...

Asahi Kasei Microdevices Corporation (AKM) will showcase its latest sensing technologies for the growing AgeTech and PetTech markets at CES® 2026. The demonstrations, featuring technologies such as ...

Precigen, Inc. ( PGEN) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Precigen Third Quarter 2025 Financial Results and Business Update ...

Papcemias FDA Approval -- Granted full FDA approval in August with the first and only available treatment for all adults with recurrent respiratory papillomatosis (RRP); label is broad with no ...

Voyager is paying travel partner Transition Bio a single-digit million-dollar upfront payment, with additional payments up to ...

CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company focused on unlocking ...

Researchers from IIT Madras and Ohio State University have developed an AI framework called PURE that can quickly generate drug-like molecules suitable for real-world synthesis. This innovation aims ...